23andMe Investor Presentation Deck

Opportunities to collaborate with 23andMe Target - Drug Discovery - Drug Development Collaborations Human genetics-driven target discovery Target Discovery Target val Lead opt IND-enabling Deeply phenotyped cohorts (e.g., Parkinson's) Phase 1 Portfolio validation Clinical trial recruitment based on genetics Phase 2 Phase 3 Marketing Genetics-driven disease awareness, cascade screening, and confirmatory testing Copyright © 2023 23and Me, Inc. 23andMe 25

View entire presentation